Received Dec 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | — | IM |
became very ill; This spontaneous case was reported by an other health care professional and describes the occurrence of ILLNESS (became very ill) in a patient of an unknown age and gender who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) 1 dosage form. On an unknown date, the patient experienced ILLNESS (became very ill) (seriousness criterion disability). At the time of the report, ILLNESS (became very ill) had not resolved. The action taken with SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) was unknown. For SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use), the reporter did not provide any causality assessments. This case was for 1st patient out of 2 patients. No concomitant medication was reported. HCP reported two patients who became very ill after receiving the Covid vaccine. They have received long lasting side effects that have changed their lives and was inquiring if Moderna offers any compensation to consumer who have become disabled by the vaccine. It was unknown if the patient experienced any additional symptoms/events. No treatment medication was reported. This case was linked to US-MODERNATX, INC.-MOD-2025-792060 (E2B Linked Report).; Reporter's Comments: Missing information regarding patient's age, medical history as well as type of illness preclude proper medical assessment. The benefit-risk relationship of the product is not affected by this report.; Sender's Comments: US-MODERNATX, INC.-MOD-2025-792060:Patient 2 out of 2